Medication Description: Somilasum
The combined enzyme preparation containing solizim (see) and a-amylase.
Available in the form of intestinal-soluble tablets (light yellow) containing 0.0286 g of solizime (20,000 LE) and 0.1363 g (300 U) of a-amylase.
Enzymes entering the preparation hydrolyze vegetable and animal fats and break down polysaccharides.
Applied with chronic pancreatitis with low lipolytic activity, chronic diseases of the gastrointestinal tract (gastritis, enteritis, enterocolitis, hepatitis, cholecystitis), as well as after operations on the pancreas, stomach, liver, and functional disorders associated with violation of the diet.
Is taken orally during a meal or immediately after a meal, 1 to 2 tablets 3 times a day, daily. The tablet is swallowed without chewing.
Storage: in a dry, dark place at a temperature no higher than + 5 'C and no lower than O'.